Your browser doesn't support javascript.
loading
Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach.
Giaccone, Luisa; Felicetti, Francesco; Butera, Sara; Faraci, Danilo; Cerrano, Marco; Dionisi Vici, Margherita; Brunello, Lucia; Fortunati, Nicoletta; Brignardello, Enrico; Bruno, Benedetto.
Afiliação
  • Giaccone L; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Felicetti F; Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
  • Butera S; Transition Unit for Childhood Cancer Survivors, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Faraci D; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Cerrano M; Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
  • Dionisi Vici M; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Brunello L; Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
  • Fortunati N; Division of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Brignardello E; Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, University of Torino, Torino, Italy.
  • Bruno B; Transition Unit for Childhood Cancer Survivors, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
J Blood Med ; 11: 141-162, 2020.
Article em En | MEDLINE | ID: mdl-32523389
ABSTRACT
The increasing indications for allogeneic stem-cell transplant in patients with hematologic malignancies and non-malignant diseases combined with improved clinical outcomes have contributed to increase the number of long-term survivors. However, survivors are at increased risk of developing a unique set of complications and late effects, besides graft-versus-host disease and disease relapse. In this setting, the management capacity of a single health-care provider can easily be overwhelmed. Thus, to provide appropriate survivorship care, a multidisciplinary approach for the long-term follow-up is essential. This review aims at summarizing the most relevant information that a health-care provider should know to establish a follow-up care plan, in the light of individual exposures and risk factors, that includes all organ systems and considers the psychological burden of these patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article